GI
APGE icon

GAMMA Investing’s Apogee Therapeutics APGE Stock Holding History

GAMMA Investing’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41K Buy
309
+89
+40% +$8.02K ﹤0.01% 2435
2026
Q1 		$18.5K Buy
220
+4
+2% +$290 ﹤0.01% 2750
2025
Q4 		$16.3K Buy
216
+73
+51% +$4.6K ﹤0.01% 2724
2025
Q3 		$5.68K Buy
143
+22
+18% +$840 ﹤0.01% 3127
2025
Q2 		$5.25K Sell
121
-24
-17% -$913 ﹤0.01% 3094
2025
Q1 		$5.42K Sell
145
-3
-2% -$116 ﹤0.01% 3055
2024
Q4 		$6.7K Buy
148
+116
+363% +$5.92K ﹤0.01% 2787
2024
Q3 		$1.88K Buy
32
+21
+191% +$1.01K ﹤0.01% 3090
2024
Q2 		$433 Sell
11
-2
-15% -$97 ﹤0.01% 3232
2024
Q1 		$864 Buy
+13
New +$568 ﹤0.01% 2977

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

GAMMA Investing's APGE Position: Q2 2026 in Review

GAMMA Investing increased its Apogee Therapeutics (APGE) stake by 40% in Q2 2026, buying an estimated $8.02K and bringing the position to 309 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

GAMMA Investing first reported a position in APGE in Q1 2024 and has held it in 10 quarters since. 14 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • GAMMA Investing held 309 shares of Apogee Therapeutics worth $41K as of Q2 2026.
  • GAMMA Investing bought 89 Apogee Therapeutics shares in Q2 2026, an estimated $8.02K.
  • Apogee Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2435 holding.
  • GAMMA Investing first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 14 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.